Illumination resembling daylight, an evenly illuminated treatment field, a long battery life also for extensive working days and a high wearing comfort – EyeMag Light II, the new LED illumination for medical loupes from ZEISS provides considerable enhancements for everyday dental and surgical routines.
The new generation of medical loupe illumination that is perfectly matched to the entire medical loupe portfolio from ZEISS offers users a brightly illuminated treatment field and high-quality, high-contrast images.
"The new LED light supports our customers in achieving an optimal treatment outcome by combining high-precision detail recognition with high wearing comfort," says Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. It remedies problems such as uneven illumination and insufficient brightness.
The combination of medical loupe and illumination can be quickly adapted to the doctor's current treatment position, therefore enabling a comfortable, ergonomic sitting position and relaxed work. Back and neck problems are effectively prevented.
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases - including implants and consumable materials. The company creates innovative visualisation solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. In financial year 2012/2013 (ended 30 September) the Group's more than 2,500 employees generated revenue of almost € 906 million.
The head office of Carl Zeiss Meditec is in Jena, Germany. The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Research and Development (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the presence in these rapidly developing economies. Around 35 percent of Carl Zeiss Meditec shares are in free float. The remaining approx. 65 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Foundation.